National Bank of Canada’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-289,300
Closed -$13.7M 2932
2021
Q4
$13.7M Buy
+289,300
New +$17.4M 0.05% 316

Other funds holding NBP

National Bank of Canada's NBP Position: Q1 2022 in Review

National Bank of Canada sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 289,300 shares — an estimated $13.7M sold.

National Bank of Canada first reported a position in NBP in Q4 2021 and held it in 1 quarter. The position peaked at $13.7M in Q4 2021. 120 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

  • National Bank of Canada reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • National Bank of Canada sold 289,300 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $13.7M.
  • National Bank of Canada first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2021 and held it in 1 quarter.
  • National Bank of Canada's NovaBridge Biosciences American Depositary Shares position peaked at $13.7M in Q4 2021.
  • 120 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on National Bank of Canada's 13F filing for Q1 2022, filed 5 May 2022.